The Application of Quantitative Parameters Obtained from DCE MRI in Evaluating Early Efficacy of Anti-Angiogenesis Drugs

丁爽,许永华,贾文霄,杨利霞,黄自丽,潘晓东
DOI: https://doi.org/10.13437/j.cnki.jcr.2014.05.034
2014-01-01
Abstract:Objective To discuss the application of quantitative parameters obtained from dynamic contrast enhanced( DCE) MRI in assessing the early effect of anti-angiogenesis drug. Methods Thirty rats with subcutaneous colon cancer xenograft model were randomly and equally divided into three groups with 10 rats in each group: the control group,the Avastin treatment group and the 5-Fu treatment group. DCE MRI was performed before the treatment( used as baseline),as well as at one,24 and 48 hours after the treatment. The following parameters were dynamically measured: microvascular permeability transfer constant( Ktrans),microvascular permeability reflux constant( Kep),volume fraction of the plasma space( Vp),extravascular extracellular volume fraction( Ve) and maximum slope of increase( MSI). After last MRI examination performed at 48 hours after the treatment,all the experimental rats were sacrificed and the specimens were sent for immunohistochemical examination. The DCE MRI parameters were quantified and correlated with immunohistochemical results. Results Statistically significant differences in Ktrans,Kep,MSI and Vp values existed between each other among the three groups. In addition,the change trend was different in different observation phase( P 0. 01). No statistically significant difference in Ve existed between each other among the three groups( F = 2. 099,P = 0. 142). One hour after the treatment,all parameters in both Avastin group and 5-Fu group decreased significantly. At 24 hours after the treatment, all parameters in Avastin group showed a persistent dropping,while in 5-Fu group the parameters showed some improvement. Ktrans,Kephad a parallel relationship with the immunohistochemical results,while no definite correlation existed between Ve,Vp,MSI and immunohistochemical results. Conclusion DCE MRI quantitative parameters can reflect the early effect of anti-angiogenesis drug and can also differentiate the early response of different drugs with different mecha-nisms. Ktransand Kepcan be used as the imaging biomarkers for non-invasive evaluation of tumor vascular closure and cell metabolism after anti-angiogenesis drugs treatment.
What problem does this paper attempt to address?